Creatine kinase and SLCO1B1 RS4363657 polymorphism in Malaysian dyslipidaemic patients prescribed with statin drugs
Background: Statin, a first line treatment for dyslipidaemia has reduced patient compliance and is underprescribed because of its side effect of muscle toxicity. The incidence of statin-induced muscle toxicity ranges from 1% to 7%, whereas severe muscle toxicity occurs in up to 0.5% of patients. In...
Saved in:
| 主要作者: | |
|---|---|
| 格式: | Thesis |
| 语言: | English |
| 出版: |
2016
|
| 主题: | |
| 在线阅读: | http://psasir.upm.edu.my/id/eprint/99069/1/FPSK%20%28m%29%202016%2037%20IR.pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|